LIFECORE BIOMEDICAL INC (LFCR)
US5147661046 - Common Stock
LIFECORE BIOMEDICAL INC
NASDAQ:LFCR (10/11/2024, 8:10:39 PM)
After market: 4.62 0 (0%)4.62
+0.13 (+3.01%)
Company Profile
Lifecore Biomedical, Inc. is a contract development and manufacturing organization, which engages in the provision of differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. The company is headquartered in Chaska, Minnesota and currently employs 459 full-time employees. The firm designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The firm offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. The company is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The firm uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
Company Info
LIFECORE BIOMEDICAL INC
3515 Lyman Boulevard
Chaska MINNESOTA
P: 19523684300
Employees: 524
Website: https://www.lifecore.com/
LFCR News
9 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update9 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update-- Recorded Revenues of $24.7 Million for Q1 Fiscal 2025 -- -- Signed Multiple New Business Agreements with New and Existing Customers -- -- More than...
9 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical Raises $24.3 Million in Private Placement of Common StockPIPE with New and Existing Investors Supports Working Capital and Operations
9 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical Raises $24.3 Million in Private Placement of Common StockPIPE with New and Existing Investors Supports Working Capital and Operations...
10 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 202410 days ago - Lifecore Biomedical, Inc.Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and...
LFCR Twits
Here you can normally see the latest stock twits on LFCR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
